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Asymmetric phenotype of Axenfeld-Rieger anomaly and aniridia
associated with a novel PITX2 mutation
Simon K. Law, Maha Sami, Natik Piri, Anne L. Coleman, Joseph Caprioli
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Purpose: To evaluate the asymmetry of the anterior segment phenotype between the two eyes of a patient with Axenfeld-
Rieger syndrome (ARS).
Methods: The entire database of a tertiary glaucoma practice was screened for patients with ARS. The medical records
of patients with ARS were reviewed. The clinical characteristics of ocular examination of the two eyes of each patient
were recorded and compared. Dental and medical information were also reviewed where available. The anterior segment
phenotype was tabulated to assess asymmetry. Asymmetric anterior segment characteristics of patients with ARS were
compared with reported cases in the literature.
Results: Eight patients with ARS were identified from screening of more than 5,000 patients of a tertiary glaucoma
practice. All patients had Axenfeld-Rieger anomaly in both eyes except one patient presented with an asymmetric
phenotype of the anterior segment with features of Axenfeld-Rieger anomaly in one eye, but aniridia in the other eye. This
patient  had  non-ocular  findings  including  flat  midface,  hypodontia  with  lack  of  an  upper  incisor,  and  redundant
periumbilical skin, typical for ARS. A heterozygous C>T nucleotide substitution was identified in exon 4 of the pituitary
homeobox 2 (PITX2) gene, resulting in the replacement of a glutamine codon (CAG) with a stop codon (TAG) at amino
acid position 67. This mutation is denoted c.199C>T at the cDNA level or p.Gln67Stop (or Q67X) at the protein level.
Only three cases with asymmetric anterior segment phenotype between the two eyes of a patient with AGS have been
reported in the literature.
Conclusions: Variability in phenotype may occur between the two eyes of an individual affected by ARS. The current
case undermines the advantage of genetic testing to correctly diagnose a rare disease.
Axenfeld-Rieger syndrome (ARS) is characterized by a
variable combination of anterior segment dysgenesis, dental
anomalies, and umbilical hernia. Reported anterior segment
features  in  ARS  include  iris  stromal  hypoplasia  (poor
development  of  the  anterior  stroma  of  the  iris),
iridogoniodysgenesis  (hypoplastic  iris  with  abnormal
“wooly”  iridocorneal  angle  tissue),  corectopia  (eccentric
pupil), polycoria (iris tears), ectropion uveae (eversion of the
pupillary  margin),  posterior  embryotoxon  (prominent  and
centrally displaced Schwalbe’s line), and iris strands bridging
the iridocorneal angle to the trabecular meshwork [1]. About
half of the patients develop secondary angle closure glaucoma
[2].  Although  there  are  a  few  cases  of  an  asymmetric
phenotype between fellow eyes of a patient with ARS, similar
anterior segment characteristics of fellow eyes are the usual
presentation [3,4]. The purpose of this study was to evaluate
the asymmetry of phenotype of the anterior segment between
the two eyes of a patient with Axenfeld-Rieger syndrome
(ARS), and present a case of ARS with asymmetric anterior
segment phenotype and the associated genotype.
Correspondence to: Simon K. Law, M.D., 100 Stein Plaza #2-235,
Jules Stein Eye Institute, Los Angeles, CA, 90095; Phone: (310)
794-1477; FAX: (310) 794-6616; email: law@jsei.ucla.edu
METHODS
The Institutional Review Board at University of California
Los Angeles, Los Angeles, CA approved the current study and
it  was  performed  in  accordance  with  the  Declaration  of
Helsinki. The entire database of a tertiary glaucoma practice
was screened to identify patients with ARS. The medical
records of patients with ARS were retrospective reviewed.
The medical data collected included the eye examination, and
dental and medical records. The clinical characteristics of the
two  eyes  of  each  patient  with  ARS  were  recorded  and
compared. The anterior segment phenotype was tabulated to
assess  asymmetry.  A  literature  review  of  asymmetric
phenotypes of the anterior segment of patients with ARS was
conducted.
In review of the preliminary data collected, one patient
had  markedly  asymmetric  anterior  segment  phenotype
between the two eyes. Genetic testing was ordered for this
patient. PCR and DNA sequencing was performed by GeneDx
(Gaithersburg, MD). Primer sequences and PCR conditions
cannot be disclosed here since GeneDx has proprietary rights
on this information.
RESULTS
Eight patients with ARS were identified from screening the
medical records of more than five thousand patients of a
tertiary  glaucoma  practice.  All  patients  had  symmetric
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1232Axenfeld anomaly and/or Rieger anomaly in both eyes, except
for one patient who presented with an asymmetric phenotype
of the anterior segment with Axenfeld-Rieger anomaly in one
eye, but aniridia in the other eye. Table 1 summarizes the
clinical characteristics of the ocular examination of the eight
patients. Except for the case (Patient MA) with a markedly
asymmetric phenotype between the two eyes, the rest of the
patients had iris stromal hypoplasia, corectopia, polycoria,
ectropion uveae, and posterior embryotoxon in both eyes.
Seven of the eight patients had glaucoma in both eyes. One
patient who had mild Axenfeld anomaly had no glaucoma in
either eye. Six patients had central corneal thickness (CCT)
measured for at least one eye. The average CCT (standard
deviation) of the right eye was 602 (40) microns and left eye
was 613 (57) microns.
In this retrospective review, the seven patients that had
bilateral ocular findings typical for ARS received no genetic
work up. However, the patient with the unusual asymmetric
phenotype with features of Axenfeld-Rieger anomaly in one
eye and aniridia in the other eye posed a diagnostic uncertainty
and systemic and genetic evaluation were performed. Details
of the clinical presentation and evaluation of this patient are
reported as follows.
Case (Patient M.A.): The patient was referred to our
institute  when  she  was  four  years  old  with  an  uncertain
diagnosis of ARS versus aniridia. Shortly before the referral,
she was found to have an increased intraocular pressure (IOP)
in both eyes: 27 mmHg in the right and 46 mmHg in the left,
and was started on glaucoma medications. When she was
using  timolol  and  dorzolamide  as  fixed  combination  and
bimatoprost eye drops in both eyes, the IOP measured by
Goldmann tonometry was 14 mmHg in the right and 32 in the
left. Her spectacle-corrected vision was 20/80 in the right and
Figure  1.  Anterior  segment  photograph  of  the  right  eye  shows
polycoria,  adhesion  of  iris  strands  with  peripheral  cornea,  and
posterior emblyotoxon.
20/40 in the left, with moderate hyperopia in the right and mild
myopia in the left. The right eye was amblyopic, and was
undergoing  occlusion  therapy.  She  has  no  strabismus  or
nystagmus. Slit lamp examination of the right eye revealed
polycoria, adhesion of iris strands to the peripheral cornea,
and posterior embryotoxon. (Figure 1) Examination of the left
eye revealed a small iris stub resembling aniridia, and a similar
appearance was noted on an old photograph taken when she
was 3 months old (Figure 2 and Figure 3).Corneal pachymetry
was 664 microns in the right and 683 microns in the left. The
horizontal corneal diameter measured 11 mm in both eyes.
Axial length by ultrasonic measurement was 21.78 mm in the
right eye and 24.46 mm in the left eye. Gonioscopy revealed
extensive iris strands bridging the iridocorneal angle to the
trabecular meshwork in the right and complete angle closure
by the stub of the iris in the left. Optic disc examination
revealed a cup/disc ratio of 0.30 in the right eye and 0.95 in
Figure 2. Anterior segment photograph of the left eye shows aniridia.
Figure 3. Old photograph of patient when she was 3 months old
shows similar anterior segment appearance.
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1233the left, and there was no retinal pathology (Figure 4 and
Figure  5).  Further  physical  examination  revealed  a  flat
midface,  hypodontia  with  lack  of  an  upper  incisor,  and
redundant  periumbilical  skin  (Figure  6  and  Figure  7).
Ultrasonic examination of kidneys was normal and there was
no cardiac abnormality. She has normal intelligence. Other
family members including both parents and a younger brother
were examined and no similar anomaly was noted. However,
the maternal uncle has Russell-Silver syndrome and was not
available to be examined.
Parents of the patient underwent genetic counseling and
consented to the genetic testing of the patient. Genomic DNA
Figure 4. Optic disc photograph of the right eye shows normal neural
rim.
Figure 5. Optic disc photograph of the left eye shows severe loss of
neural rim.
from  the  patient’s  blood  sample  was  PCR-amplified  and
screened  for  mutations  in  pituitary  homeobox  2  (PITX2),
forkhead box C1 (FOXC1), and paired box 6 (PAX6) genes
that are known to be associated with ARS. Coding exons of
PITX2b  (NM_153426)  were  analyzed  in  this  study.  A
heterozygous  C>T  nucleotide  substitution  (a  nonsense
mutation) was identified in exon 4 of PITX2, resulting in the
replacement of a glutamine codon (CAG) with a stop codon
(TAG) at amino acid position 67. This mutation is denoted c.
199C>T at the cDNA level or p.Gln67Stop (or Q67X) at the
protein  level  (Figure  8).  No  sequence  alterations  were
detected in FOXC1 and PAX6.
She subsequently received a tube shunt procedure in the
left eye and an additional tube shunt procedure 2 years later
Figure  6.  Facial  photograph  of  patient  shows  flat  midface  and
hypodontia lacking of an upper incisor.
Figure  7.  Abdominal  photograph  of  patient  shows  redundant
periumbilical skin.
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1234with pressure of the left eye controlled at 20–22 mmHg on
minimum topical medication.
Literature  review:  A  literature  review  identified
asymmetric  phenotypes  of  the  anterior  segment  in  three
patients with ARS (Table 2). In 1883, Vossius [5] described
a nine-year-old girl with bilateral iris defects associated with
dental anomalies. One eye had an ectopic pupil (corectopia)
with full-thickness iris stromal defects (polycoria) while the
fellow eye had a near-total absence of iris tissue (aniridia).
The other two patients were reported by Perveen et al. [4] in
2000. These two patients had unilateral Peters anomaly in one
eye but the other eye had Rieger anomaly or iris hypoplasia
[4].
DISCUSSION
Although tremendous variability in phenotype within a single
family with ARS has been observed, phenotypes between the
two eyes of an affected individual are usually similar [1].
Seven of the eight patients with ARS in our tertiary glaucoma
practice presented with a similar anterior segment phenotype
between the two eyes. However, one patient presented with
anterior segment features of Axenfeld-Rieger anomaly in one
eye,  and  aniridia  in  the  other  eye.  In  1883,  Vossius  [5]
described a nine-year-old girl with Rieger anomaly in one eye
including an ectopic pupil with full-thickness iris stromal
defects, while the fellow eye had a near-total absence of iris
tissue  (aniridia).  To  our  knowledge,  description  of  the
asymmetric phenotype of Axenfeld-Rieger anomaly in one
eye and severe iris hypoplasia resembling aniridia in the other
eye has not been previously reported.
It  is  known  that  mutations  in  the  transcription  factor
PITX2 and FOXC1 genes lead to ARS, while mutations of the
PAX6 gene underlies many cases of aniridia [6,7]. However,
Henkind and associates [8] described a family with ARS that
included two members who appeared to have aniridia. In
addition, cases of ARS have been described associated with a
deletion of PAX6 [6,9,10], and cases of bilateral aniridia with
proven PITX2 and FOXC1 mutations [4,11]. Because of the
mixed anterior segment anomalies between the two eyes of
this patient and the association of Wilm’s tumor in sporadic
cases of aniridia,  genetic  testing  was conducted for PITX2,
 FOXC1,  and  PAX6    [6].   The   nonsense   mutation,   Q67X,
Figure 8. Sequencing analysis of the Axenfeld-Rieger syndrome
patient’s PITX2 gene with the C>T mutation.
in exon 4 of PITX2 identified has not previously been reported,
to our knowledge [7].
PITX2 mutations are primarily responsible for ARS but
have  also  been  associated  with  Peters  anomaly,  iris
hypoplasia/iridogoniodysgenesis syndrome, aniridia, and ring
dermoid  of  the  cornea  [4,7,12].  Intragenic  mutations  of
PITX2 have been described in more than 40 ARS patients to
date and include missense, nonsense, splice-site mutations,
and deletions/insertions/duplications. There is no apparent
correlation between the mutation location in PITX2 and the
severity  of  the  clinical  phenotype.  However,  the
characterization of several missense mutations indicates that
the  severity  of  the  phenotype  can  be  correlated  to  the
remaining function of the mutant PITX2. In heterozygotes,
the function of one wild-type PITX2 allele alone results in the
severe ARS form. Contribution of the mutant allele would
result in the milder iris hypolasia or iridogoniodysgenesis
syndrome forms, depending on the degree of residual activity
[13]. A nonsense mutation in PITX2 found in patient M.A. is
predicted  to  result  in  degradation  of  the  mutant  mRNA
through the nonsense-mediated decay pathway that prevent
the  synthesis  of  the  truncated  protein  [14].  Even  if  the
truncated 66 amino acid (aa) long protein is synthesized and
stable, it would be shorter than the native protein by 251 aa
and would lack helix 2 and helix 3/4 of the DNA binding
homeodomain involved in transcriptional regulation and the
OAR  domain  in  the  COOH-terminal  end  that  has  been
proposed to increase the DNA binding and transcriptional
activity of PITX2 during development [15]. The absence of
clinical and genetic abnormalities in other family members
suggests that this may be a de novo genomic alteration [3].
Finally, since PITX2 is known to inhibit FOXC1 activity
[16], the mechanism for PITX2-related severity of the ocular
phenotype  in  this  patient  may  be  the  simultaneous
consequence  of  PITX2  haploinsufficiency  and  a  gain  of
function of FOXC1.
Mutations  of  PITX2  are  usually  associated  with  full-
spectrum  ARS  phenotypes  that  include  both  ocular  and
nonocular features, as in patient M.A [1]. Intriguingly, PITX2
is  also  involved  in  left-right  polarity  determination,  yet
asymmetry defects are not a usual feature of ARS [3,4,17].
Iris abnormalities are usually stationary, but rarely have been
demonstrated to change over time [18]. In our patient, the
aniridia in the left eye appears to remain unchanged since
infancy by comparison with old photographs. Aniridia is a
panocular disease with associated ocular and visual defects
such as corneal opacification, cataract, foveal dysplasia, optic
nerve hypoplasia, and nystagmus, but none of which is found
in this patient [6]. It is possible that the different phenotypes
of iris abnormality in the two eyes of this patient fall within a
spectrum of iris defect in ARS.
The  major  clinical  concern  in  ARS  is  the  risk  of
developing sight-threatening glaucoma, which is estimated to
Molecular Vision 2011; 17:1231-1238 <http://www.molvis.org/molvis/v17/a138> © 2011 Molecular Vision
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1236occur  in  50%  of  the  patients  [1,2].  Although  physical
occlusion of the angle structure is not prerequisite for elevated
IOP and glaucoma in ARS, the severity of glaucoma does
correlate with the level of iris insertion into the angle [2]. In
the seven patients of this series who had glaucoma in both
eyes,  the  eye  with  more  extensive  areas  of  angle  closure
presented with higher IOP and was more resistant to medical
and surgical management.
Patients  in  this  series  had  a  thicker  central  cornea
compared  to  normal  adults,  and  a  thick  central  cornea  is
associated  with  artificially  higher  IOP  estimation  by
applanation.  Pachymetry  of  patients  with  ARS  is  rarely
reported  in  the  literature.  In  mouse  models  with
overexpressing  PITX2A  isoform  in  the  cornea,  corneal
hypertrophy was noted together with iridocorneal adhesion,
gray and tearing eyes, and severe apoptosis-associated retinal
degeneration  [19].  In  human  with  ARS-causing  PITX2
mutation, V45L, elevated transactivating properties in cell
culture were found [20]. It is suggestive that increased as well
as  reduced  PITX2  activities  are  deleterious  during
development [17]. Further functional studies may clarify if the
novel mutation of PITX2 found in our patient is associated
with a gain-of-function leading to an increase of thickness of
the cornea.
In summary, although phenotypic presentation of ARS is
highly variable within a single family, only a few cases in the
literature had different phenotypes between the two eyes of
an  individual.  We  presented  a  case  of  an  asymmetric
phenotype  of  Axenfeld-Rieger  anomaly  in  one  eye  and
aniridia in another of a patient with a novel nonsense point
mutation  of  PITX2.  The  current  case  undermines  the
variability in phenotype even between the two eyes of an
individual  affected  by  ARS  and  the  advantage  of  genetic
testing in correctly diagnosing a rare disease.
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